FragmentStore-A comprehensive database of fragments linking metabolites, toxic molecules and drugs

Nucleic Acids Research

Volumn 39, Issue SUPPL. 1, 2011, Pages

  Ahmed, Jessica ^a   Worth, Catherine L ^a   Thaben, Paul ^a   Matzig, Christian ^a   Blasse, Corinna ^a   Dunkel, Mathias ^a   Preissner, Robert ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; DRUG; ENZYME; TOXIN;

ARTICLE; BINDING SITE; BIOSYNTHESIS; CALCULATION; CLASSIFICATION; DATA BASE; DEGRADATION; FRAGMENTSTORE; METABOLITE; MOLECULAR LIBRARY; MOLECULAR WEIGHT; PRIORITY JOURNAL;

BINDING SITES; DATABASES, FACTUAL; DRUG DESIGN; DRUG TOXICITY; METABOLIC NETWORKS AND PATHWAYS; PHARMACEUTICAL PREPARATIONS;

EID: 78651308983     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkq969     Document Type: Article

References (24)

1. Muto, A., Hattori, M. and Kanehisa, M. (2007) Analysis of common substructures of metabolic compounds within the different organism groups. Genome Inform., 18, 299-307.
2. Enna, S.J. and Williams, M. (2009) The decreased number of new drug approvals (NDAs) has been a topic of considerable debate over the past decade. Preface. Adv. Pharmacol., 57, xi-ii.
3. Kola, I. and Landis, J. (2004) Can the pharmaceutical industry reduce attrition rates? Nat. Rev. Drug Discov., 3, 711-715.
4. Kennedy, T. (1997) Managing the drug discovery/development interface. Drug Discov. Today, 2, 436-444.
5. Bajorath, J. (2008) Computational analysis of ligand relationships within target families. Curr. Opin. Chem. Biol., 12, 352-358.
6. Chen, B., Wild, D. and Guha, R. (2009) PubChem as a source of polypharmacology. J. Chem. Inf. Model., 49, 2044-2055.
7. Keiser, M.J., Setola, V., Irwin, J.J., Laggner, C., Abbas, A.I., Hufeisen, S.J., Jensen, N.H., Kuijer, M.B., Matos, R.C., Tran, T.B. et al. (2009) Predicting new molecular targets for known drugs. Nature, 462, 175-181.
8. Kuhn, M., Campillos, M., Gonzalez, P., Jensen, L.J. and Bork, P. (2008) Large-scale prediction of drug-target relationships. FEBS Lett., 582, 1283-1290.
9. Hajduk, P.J. and Greer, J. (2007) A decade of fragment-based drug design: Strategic advances and lessons learned. Nat. Rev. Drug Discov., 6, 211-219.
10. Siegel, M.G. and Vieth, M. (2007) Drugs in other drugs: A new look at drugs as fragments. Drug Discov. Today, 12, 71-79.
11. Kotera, M., McDonald, A.G., Boyce, S. and Tipton, K.F. (2008) Functional group and substructure searching as a tool in metabolomics. PLoS One, 3, e1537.
12. Committee on Toxicity Testing and Assessment of Environmental Agents, National Research Council of The National Academies. (2007) Toxicity Testing in the 21st Century: A Vision and A Strategy. The National Academies Press, Washington, DC.
13. Berman, H.M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T.N., Weissig, H., Shindyalov, I.N. and Bourne, P.E. (2000) The Protein Data Bank. Nucleic Acids Res., 28, 235-242.
14. Lo Conte, L., Ailey, B., Hubbard, T.J., Brenner, S.E., Murzin, A.G. and Chothia, C. (2000) SCOP: A structural classification of proteins database. Nucleic Acids Res., 28, 257-259.
15. Kanehisa, M. (2002) The KEGG database. Novartis Found. Symp., 247, 91-101; discussion 101-103, 119-128, 244-152.
16. Schmidt, U., Struck, S., Gruening, B., Hossbach, J., Jaeger, I.S., Parol, R., Lindequist, U., Teuscher, E. and Preissner, R. (2009) SuperToxic: A comprehensive database of toxic compounds. Nucleic Acids Res., 37, D295-D299.
17. Kanehisa, M., Goto, S., Furumichi, M., Tanabe, M. and Hirakawa, M. (2010) KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res., 38, D355-D360.
18. Wishart, D.S., Knox, C., Guo, A.C., Cheng, D., Shrivastava, S., Tzur, D., Gautam, B. and Hassanali, M. (2008) DrugBank: A knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res., 36, D901-D906.
19. Lewell, X.Q., Judd, D.B., Watson, S.P. and Hann, M.M. (1998) RECAP - retrosynthetic combinatorial analysis procedure: A powerful new technique for identifying privileged molecular fragments with useful applications in combinatorial chemistry. J. Chem. Inf. Comput. Sci., 38, 511-522.
20. Congreve, M., Carr, R., Murray, C. and Jhoti, H. (2003) A 'rule of three' for fragment-based lead discovery? Drug Discov. Today, 8, 876-877.
21. DeLano, W.L. The PyMOL Molecular Graphics System. Schrödinger, LLC.
22. Lipinski, C.A. (2003) Chris Lipinski discusses life and chemistry after the Rule of Five. Drug Discov. Today, 8, 12-16.
23. Unterhalt, M., Herrmann, R., Tiemann, M., Parwaresch, R., Stein, H., Trumper, L., Nahler, M., Reuss-Borst, M., Tirier, C., Neubauer, A. et al. (1996) Prednimustine, mitoxantrone (PmM) vs cyclophosphamide, vincristine, prednisone (COP) for the treatment of advanced low-grade non-Hodgkin's lymphoma. German Low-Grade Lymphoma Study Group. Leukemia, 10, 836-843.
24. Ross, W.C. (1964) Aryl-2-Halogenoalkylarylamines. Xxi. The design of agents to exploit differences in cellular oxidation-reduction potentials. Biochem. Pharmacol., 13, 969-982.